In contrast, GLP-1RAs provide an effective alternative, achieving robust glycemic control with a lower risk of hypoglycemia and reduced variability 28
Benefits Beyond Weight Loss: Metabolic and Cardiovascular Health Cardiovascular risk reduction semaglutide reduced major cardiovascular events by 20% in the SELECT trial Blood sugar control significant HbA1c reductions in patients with type 2 diabetes or prediabetes Reduced liver fat growing evidence supports GLP-1 therapy for NAFLD and MASLD Sleep apnea improvement tirzepatide demonstrated 63% reduction in apnea-hypopnea index (2024 NEJM trial) Fatty Liver Disease & GLP-1 Therapy Patients with NAFLD/MASLD may see significant improvement with GLP-1 treatment
The full body composition shift is still developing at this stage
When consumed in large doses, it can cause your pee to turn bright yellow
APN, anterior pretectal nucleus
Wootten D, Miller LJ, Koole C, Christopoulos A, Sexton PM